Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $38.0B |
| FY2017, ended Dec 31, 2017 | $57.5B |
| FY2018, ended Dec 31, 2018 | $67.5B |
| FY2019, ended Dec 31, 2019 | $76.2B |
| FY2020, ended Dec 31, 2020 | $78.6B |
| FY2021, ended Dec 31, 2021 | $112B |
| FY2022, ended Dec 31, 2022 | $122B |
| FY2023, ended Dec 31, 2023 | $110B |
| FY2024, ended Dec 31, 2024 | $83.9B |
| FY2025, ended Dec 31, 2025 | $77.4B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $84.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $84.9B |
| FY2017, ended Dec 31, 2017 | $90.0B |
| FY2018, ended Dec 31, 2018 | $92.1B |
| FY2019, ended Dec 31, 2019 | $104B |
| FY2020, ended Dec 31, 2020 | $122B |
| FY2021, ended Dec 31, 2021 | $139B |
| FY2022, ended Dec 31, 2022 | $157B |
| FY2023, ended Dec 31, 2023 | $171B |
| FY2024, ended Dec 31, 2024 | $177B |
| FY2025, ended Dec 31, 2025 | $199B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $202B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.47B | $2.69B |
| FY2017, ended Dec 31, 2017 | $3.84B | $3.39B |
| FY2018, ended Dec 31, 2018 | $3.75B | $2.62B |
| FY2019, ended Dec 31, 2019 | $4.81B | $4.98B |
| FY2020, ended Dec 31, 2020 | $4.57B | $9.67B |
| FY2021, ended Dec 31, 2021 | $6.16B | $7.28B |
| FY2022, ended Dec 31, 2022 | $5.89B | $7.25B |
| FY2023, ended Dec 31, 2023 | $5.99B | $6.76B |
| FY2024, ended Dec 31, 2024 | $5.98B | $4.55B |
| FY2025, ended Dec 31, 2025 | $5.66B | $3.17B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $5.14B | $6.51B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.08B |
| FY2017, ended Dec 31, 2017 | $3.61B |
| FY2018, ended Dec 31, 2018 | $3.93B |
| FY2019, ended Dec 31, 2019 | $4.94B |
| FY2020, ended Dec 31, 2020 | $5.74B |
| FY2021, ended Dec 31, 2021 | $4.88B |
| FY2022, ended Dec 31, 2022 | $7.39B |
| FY2023, ended Dec 31, 2023 | $6.53B |
| FY2024, ended Dec 31, 2024 | $8.29B |
| FY2025, ended Dec 31, 2025 | $9.49B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $10.3B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.7B |
| FY2017, ended Dec 31, 2017 | $19.9B |
| FY2018, ended Dec 31, 2018 | $19.2B |
| FY2019, ended Dec 31, 2019 | $20.1B |
| FY2020, ended Dec 31, 2020 | $20.0B |
| FY2021, ended Dec 31, 2021 | $23.0B |
| FY2022, ended Dec 31, 2022 | $24.1B |
| FY2023, ended Dec 31, 2023 | $25.1B |
| FY2024, ended Dec 31, 2024 | $31.2B |
| FY2025, ended Dec 31, 2025 | $32.0B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $30.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 18.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 264M |
| FY2017, ended Dec 31, 2017 | 256M |
| FY2018, ended Dec 31, 2018 | 257M |
| FY2019, ended Dec 31, 2019 | 252M |
| FY2020, ended Dec 31, 2020 | 245M |
| FY2021, ended Dec 31, 2021 | 241M |
| FY2022, ended Dec 31, 2022 | 237M |
| FY2023, ended Dec 31, 2023 | 233M |
| FY2024, ended Dec 31, 2024 | 227M |
| FY2025, ended Dec 31, 2025 | 221M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 216M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $165M | $0 |
| FY2017, ended Dec 31, 2017 | $2.00B | $170M | $0 |
| FY2018, ended Dec 31, 2018 | $1.69B | $226M | $1.25B |
| FY2019, ended Dec 31, 2019 | $1.70B | $294M | $0 |
| FY2020, ended Dec 31, 2020 | $2.70B | $283M | $0 |
| FY2021, ended Dec 31, 2021 | $1.90B | $255M | — |
| FY2022, ended Dec 31, 2022 | $2.32B | $264M | — |
| FY2023, ended Dec 31, 2023 | $2.68B | $289M | — |
| FY2024, ended Dec 31, 2024 | $2.90B | $191M | — |
| FY2025, ended Dec 31, 2025 | $2.60B | $276M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.16B | $240M | — |
Valuation
At current price- Market Cap
- $91.1B
- P/E
- 17.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.5×
- Price / Book
- 2.0×
- EV / EBITDA
- 16.1×
Growth
Trailing 12 months- Revenue (TTM)
- $202B
- Revenue Growth YoY
- 3.6%
- Revenue CAGR 3Y
- 8.3%
- Revenue CAGR 5Y
- 10.3%
- EPS Growth YoY
- −4.0%
- Net Income Growth YoY
- −7.1%
Profitability
Trailing 12 months- Gross Margin
- 89.0%
- Operating Margin
- 2.7%
- Net Margin
- 2.5%
- FCF Margin
- 3.2%
- Return on Equity
- 11.6%
Earnings
Trailing 12 months- Net Income
- $5.14B
- EPS (diluted)
- $23.55
- EBITDA
- $6.92B
- Operating Income
- $5.43B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $10.3B
- Total Debt
- $30.8B
- Net Debt
- $20.4B
- Total Assets
- $128B
- Total Liabilities
- $83.0B
- Shareholders' Equity
- $44.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $7.60B
- Capital Expenditure
- $1.08B
- Free Cash Flow
- $6.51B
Dividends and risk
Last 12 months- Dividend Yield
- 1.6%
- Dividend / Share
- $6.87
- Beta (5Y)
- 0.70
Every ratio is calculated from the company’s reported figures.